The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years
Open accessAbstract
Silymarin is the extract of Silybum marianum, or milk thistle, and its major active compound is silybin, which has a remarkable biological effect. It is used in different liver disorders, particularly chronic liver diseases, cirrhosis and hepatocellular carcinoma, because of its antioxidant, anti-inflammatory and antifibrotic power. Indeed, the anti-oxidant and anti-inflammatory effect of silymarin is oriented towards the reduction of virus-related liver damages through inflammatory cascade softening and immune system modulation. It also has a direct antiviral effect associated with its intravenous administration in hepatitis C virus infection. With respect to alcohol abuse, silymarin is able to increase cellular vitality and to reduce both lipid peroxidation and cellular necrosis. Furthermore, silymarin/silybin use has important biological effects in non-alcoholic fatty liver disease. These substances antagonize the progression of non-alcoholic fatty liver disease, by intervening in various therapeutic targets: oxidative stress, insulin resistance, liver fat accumulation and mitochondrial dysfunction. Silymarin is also used in liver cirrhosis and hepatocellular carcinoma that represent common end stages of different hepatopathies by modulating different molecular patterns. Therefore, the aim of this review is to examine scientific studies concerning the effects derived from silymarin/silybin use in chronic liver diseases, cirrhosis and hepatocellular carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.012 · Cited by 3,119
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2009) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,973
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism
Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G.-H., Tan, Y., Zhang, Z., Lin, X., & He, X. (2002) · Cell · doi:10.1016/s0092-8674(02)00685-2 · Cited by 2,069
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595
Huang, S., & Czech, M. P. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.03.006 · Cited by 1,385
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Starley, B. Q., Calcagno, C. J., & Harrison, S. A. (2010) · Hepatology · doi:10.1002/hep.23594 · Cited by 1,336
Validating survivin as a cancer therapeutic target
Altieri, D. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc968 · Cited by 1,206
Charlton, M. R., Burns, J. M., Pedersen, R. A., Watt, K. D., Heimbach, J. K., & Dierkhising, R. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.061 · Cited by 1,106
Younossi, Z. M., Otgonsuren, M., Henry, L., Venkatesan, C., Mishra, A., Erario, M., & Hunt, S. (2015) · Hepatology · doi:10.1002/hep.28123 · Cited by 802
Milk Thistle (Silybum marianum) for the Therapy of Liver Disease
Flora, K. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(97)00082-8 · Cited by 746
The Use of Silymarin in the Treatment of Liver Diseases
Saller, R., Meier, R., & Brignoli, R. (2001) · Drugs · doi:10.2165/00003495-200161140-00003 · Cited by 718
Hart, M., Concordet, J.-P., Lassot, I., Albert, I., del los Santos, R., Durand, H., Perret, C., Rubinfeld, B., Margottin, F., Benarous, R., et al. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80091-8 · Cited by 671
Bataller, R., Schwabe, R. F., Choi, Y. H., Yang, L., Paik, Y. H., Lindquist, J., Qian, T., Schoonhoven, R., Hagedorn, C. H., Lemasters, J. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18212 · Cited by 548
Causes and Metabolic Consequences of Fatty Liver
Stefan, N., Kantartzis, K., & Häring, H.-U. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0009 · Cited by 532
Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
Pradhan, S. C., & Girish, C. (2006) · PubMed · Cited by 516
Silybin and silymarin - new effects and applications
Křen, V., & Walterová, D. (2005) · Biomedical Papers · doi:10.5507/bp.2005.002 · Cited by 446
Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma
Yasui, K., Hashimoto, E., Komorizono, Y., Koike, K., Arii, S., Imai, Y., Shima, T., Kanbara, Y., Saibara, T., Mori, T., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.01.023 · Cited by 420
Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Anderson, N., & Borlak, J. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00001 · Cited by 385
Silybin and the liver: From basic research to clinical practice
Loguercio, C. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i18.2288 · Cited by 375
Self-citationNonalcoholic fatty liver disease: A review of current understanding and future impact
Charlton, M. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00440-9 · Cited by 350
Pathological Features of Fatty Liver Disease
Yeh, M. M., & Brunt, E. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.056 · Cited by 346
Independent Predictors of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Hossain, N., Afendy, A., Stepanova, M., Nader, F., Srishord, M., Rafiq, N., Goodman, Z., & Younossi, Z. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.06.007 · Cited by 342
A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients
Flaig, T. W., Gustafson, D. L., Su, L.-J., Zirrolli, J. A., Crighton, F., Harrison, G. S., Pierson, A. S., Agarwal, R., & Glodé, L. M. (2007) · Investigational New Drugs · doi:10.1007/s10637-006-9019-2 · Cited by 315
Zhang, S., & Morris, M. E. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.044412 · Cited by 309
Boigk, G., Stroedter, L., Herbst, H., Waldschmidt, J., Riecken, E. O., & Schuppan, D. (1997) · Hepatology · doi:10.1002/hep.510260316 · Cited by 293
PCNA on the crossroad of cancer
Stoimenov, I., & Helleday, T. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370605 · Cited by 289
Inflammation and endoplasmic reticulum stress in obesity and diabetes
Hotamisligil, G. S. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.238 · Cited by 285
Agarwal, R. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00385-3 · Cited by 280
Kim, N.-C., Graf, T. N., Sparacino, C. M., Wani, M. C., & Wall, M. E. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b300099k · Cited by 278
Loguercio, C., Andreone, P., Brisc, C., Brisc, M. C., Bugianesi, E., Chiaramonte, M., Cursaro, C., Danila, M., de Sio, I., Floreani, A., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.008 · Cited by 267
Self-citationHézode, C., Fontaine, H., Dorival, C., Zoulim, F., Larrey, D. G., Canva, V., de Lédinghen, V., Poynard, T., Samuel, D., Bourlière, M., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.051 · Cited by 259
Non Alcoholic Fatty Liver: Epidemiology and Natural History
Masarone, M., Federico, A., Abenavoli, L., Loguercio, C., & Persico, M. (2015) · Reviews on Recent Clinical Trials · doi:10.2174/1574887109666141216111143 · Cited by 247
Self-citationFerenci, P., Scherzer, T., Kerschner, H., Rutter, K., Beinhardt, S., Hofer, H., Schöniger–Hekele, M., Holzmann, H., & Steindl–Munda, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.072 · Cited by 241
Trappoliere, M., Caligiuri, A., Schmid, M., Bertolani, C., Failli, P., Vizzutti, F., Novo, E., Manzano, C. D., Marra, F., Loguercio, C., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.02.023 · Cited by 238
Self-citationGodos, J., Zappalà, G., Bernardini, S., Giambini, I., Bes-Rastrollo, M., & Martinez-Gonzalez, M. (2017) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2016.1221900 · Cited by 236
Multiple Effects of Silymarin on the Hepatitis C Virus Lifecycle
Wagoner, J., Negash, A., Kane, O. J., Martinez, L. E., Nahmias, Y., Bourne, N., Owen, D. M., Grove, J., Brimacombe, C., McKeating, J. A., et al. (2010) · Hepatology · doi:10.1002/hep.23587 · Cited by 232
Protective effect of silymarin on oxidative stress in rat brain
Nencini, C., Giorgi, G., & Micheli, L. (2007) · Phytomedicine · doi:10.1016/j.phymed.2006.02.005 · Cited by 228
Barzaghi, N., Crema, F., Gatti, G., Pifferi, G., & Perucca, E. (1990) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190223 · Cited by 226
Reddy, S. K., Steel, J. L., Chen, H.-W., DeMateo, D. J., Cardinal, J., Behari, J., Humar, A., Marsh, W. J., Geller, D. A., & Tsung, A. (2012) · Hepatology · doi:10.1002/hep.25536 · Cited by 224
An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin
Saller, R., Brignoli, R., Melzer, J., & Meier, R. (2008) · Forschende Komplementärmedizin / Research in Complementary Medicine · doi:10.1159/000113648 · Cited by 214
Wang, M., Lin, W., Chen, H., Chang, Y., Ou, H., Kuo, J., Hong, J., & Jeng, K. G. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02290.x · Cited by 213
Silymarin Protects Against Acute Ethanol‐Induced Hepatotoxicity in Mice
Song, Z., Deaciuc, I., Song, M., Lee, D. Y. ‐., Liu, Y., Ji, X., & McClain, C. (2006) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00063.x · Cited by 190
Silymarin treatment of viral hepatitis: a systematic review
Mayer, K. É., Myers, R. P., & Lee, S. S. (2005) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00636.x · Cited by 188
A 360-degree overview of paediatric NAFLD: Recent insights
Nobili, V., Svegliati-Baroni, G., Alisi, A., Miele, L., Valenti, L., & Vajro, P. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.003 · Cited by 171
Younossi, Z. M., Otgonsuren, M., Venkatesan, C., & Mishra, A. (2013) · Metabolism · doi:10.1016/j.metabol.2012.08.005 · Cited by 169
Silymarin Retards the Progression of Alcohol-Induced Hepatic Fibrosis in Baboons
Lieber, C. S., Leo, M. A., Cao, Q., Ren, C., & DeCarli, L. M. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200310000-00013 · Cited by 156
Jia, J., Bauer, M. W., Cho, J. J., Ruehl, M., Milani, S., Boigk, G., Riecken, E. O., & Schuppan, D. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00148-9 · Cited by 154
Hawke, R. L., Schrieber, S. J., Soule, T. A., Wen, Z., Smith, P. C., Reddy, K. R., Wahed, A. S., Belle, S. H., Afdhal, N. H., Navarro, V. J., et al. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009347475 · Cited by 152
Antioxidant and Hepatoprotective Effects of Silibinin in a Rat Model of Nonalcoholic Steatohepatitis
Haddad, Y. K., Vallerand, D., Brault, A., & Haddad, P. S. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep164 · Cited by 149
Is genotype 3 of the hepatitis C virus the new villain?
Goossens, N., & Negro, F. (2013) · Hepatology · doi:10.1002/hep.26905 · Cited by 147
Serviddio, G., Pereda, J., Pallardó, F. V., Carretero, J., Borrás, C., Cutrìn, J. C., Vendemiale, G., Poli, G., Viña, J., & Sastre, J. (2004) · Hepatology · doi:10.1002/hep.20101 · Cited by 147
Tyagi, A. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh180 · Cited by 144
Food Constituents Attenuate Monoamine Oxidase Activity and Peroxide Levels in C6 Astrocyte Cells
MAZZIO, E. A., Harris, N. D., & Soliman, K. F. A. (1998) · Planta Medica · doi:10.1055/s-2006-957530 · Cited by 138
Prostate Cancer Prevention by Silibinin
Singh, R. P., & Agarwal, R. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043481605 · Cited by 136
Effect of Flavonoids on MRP1-Mediated Transport in Panc-1 Cells
Nguyen, H. T. T., Zhang, S., & Morris, M. E. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10283 · Cited by 131
Milk Thistle and Its Derivative Compounds: A Review of Opportunities for Treatment of Liver Disease
Hackett, E. S., Twedt, D. C., & Gustafson, D. L. (2012) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12002 · Cited by 125
Silymarin Inhibits the Development of Diet-Induced Hypercholesterolemia in Rats
Krecman, V., Škottová, N., Walterová, D., Ulrichová, J., & Šimánek, V. (1998) · Planta Medica · doi:10.1055/s-2006-957391 · Cited by 123
Zhang, S., & Morris, M. E. (2003) · Pharmaceutical Research · doi:10.1023/a:1025044913766 · Cited by 120
The role of oxidative stress in the development of alcoholic liver disease
Galicia‐Moreno, M., & Gutiérrez‐Reyes, G. (2014) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2014.06.007 · Cited by 120
Jain, A., Yadav, A., Божков, А. И., Padalko, V., & Flora, S. J. S. (2010) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2010.08.002 · Cited by 118
Loguercio, C., Federico, A., Trappoliere, M., Tuccillo, C., de Sio, I., Di Leva, A., Niosi, M., D’Auria, M. V., Capasso, R., Blanco, C. D. V., et al. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9703-2 · Cited by 116
Self-citationClichici, S. V., Olteanu, D. E., Nagy, A.-L., Oros, A., Filip, G. A., & Mircea, P. A. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2013.0179 · Cited by 102
ROLE OF MACROPHAGES IN ACETAMINOPHEN (PARACETAMOL)-INDUCED HEPATOTOXICITY
Goldin, R. D., Ratnayaka, I., BREACH, C. S., Brown, I. N., & Wickramasinghe, S. N. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199608)179:4<358::aid-path564>3.0.co;2-t · Cited by 102
Effects and mechanisms of silibinin on human hepatoma cell lines
Lah, J. J., Cui, W., & Hu, K.-Q. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i40.5299 · Cited by 100
Federico, A., Dallio, M., Godos, J., Loguercio, C., & Salomone, F. (2015) · Translational research · doi:10.1016/j.trsl.2015.08.002 · Cited by 97
Self-citationHepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe
Petruzziello, A., Marigliano, S., Loquercio, G., et al. (2016) · Infectious Agents and Cancer · doi:10.1186/s13027-016-0099-0 · Cited by 97
Mediterranean diet and nonalcoholic fatty liver disease: molecular mechanisms of protection
Godos, J., Federico, A., Dallio, M., & Scazzina, F. (2016) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2016.1214239 · Cited by 94
Self-citationNi, X., & Wang, H. (2016) · PubMed · Cited by 93
Yao, J., Zhi, M., Gao, X., Hu, P., Li, C., & Yang, X. (2013) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20122551 · Cited by 91
Federico, A., Trappoliere, M., Tuccillo, C., de Sio, I., Leva, A. D., Blanco, C. D. V., & Loguercio, C. (2006) · Gut · doi:10.1136/gut.2006.091967 · Cited by 90
Self-citationMeeran, S. M., Katiyar, S., Elmets, C. A., & Katiyar, S. K. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0095 · Cited by 88
Blaising, J., Levy, P. L., Gondeau, C., Phelip, C., Varbanov, M., Teissier, É., Ruggiero, F., Polyak, S. J., Oberlies, N. H., Ivanovic, T., et al. (2013) · Cellular Microbiology · doi:10.1111/cmi.12155 · Cited by 87
Stiuso, P., Scognamiglio, I., Murolo, M., Ferranti, P., Simone, C. D., Rizzo, M. R., Tuccillo, C., Caraglia, M., Loguercio, C., & Federico, A. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/169216 · Cited by 83
Self-citationPlíšková, M., Vondráček, J., Křen, V., Gažák, R., Sedmera, P., Walterová, D., Psotová, J., Šimánek, V., & Machala, M. (2005) · Toxicology · doi:10.1016/j.tox.2005.06.020 · Cited by 81
Muriel, P., Moreno, M. G., Hernandez, M. D. C., Chávez, E. R., & Alcantar, L. K. (2005) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2005.pto_06.x · Cited by 80
Kiruthiga, P. V., Shafreen, R. B., Pandian, S. K., Arun, S., Govindu, S., & Devi, K. P. (2007) · Chemosphere · doi:10.1016/j.chemosphere.2007.03.015 · Cited by 80
Silymarin nanoparticle prevents paracetamol-induced hepatotoxicity
Mukherjee, A., Das, Roy, P., & Auddy, R. G. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s15160 · Cited by 80
Serviddio, G., Bellanti, F., Stanca, E., Lunetti, P., Blonda, M., Tamborra, R., Siculella, L., Vendemiale, G., Capobianco, L., & Giudetti, A. M. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.05.002 · Cited by 79
Sinnberg, T. W., Menzel, M., Kaesler, S., Biedermann, T., Sauer, B., Nahnsen, S., Schwarz, M., Garbe, C., & Schittek, B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0645 · Cited by 79
Metabolic effects of silibinin in the rat liver
Colturato, C. P., Constantin, R. P., Júnior, A. S. M., Constantin, R. P., Yamamoto, N. S., Bracht, A., Ishii‐Iwamoto, E. L., & Constantin, J. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.11.006 · Cited by 79
Silymarin and Its Role in Chronic Diseases
Neha, N., Jaggi, A. S., & Singh, N. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-41342-6_2 · Cited by 75
Li, H. B., Yang, Y., Mo, Z. J., Ding, Y.-B., & Jiang, W. (2015) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20144238 · Cited by 72
Momeny, M., Khorramizadeh, M. R., Ghaffari, S. H., Yousefi, M., Yekaninejad, M. S., Esmaeili, R., Jahanshiri, Z., & Noori–Daloii, M. R. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.011 · Cited by 72
Sayyah, M., Boostani, H., Pakseresht, S., & Malayeri, A. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.12.016 · Cited by 71
Wang, J., Chang, C., Chiang, C., Chen, W., & Hung, S. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24043 · Cited by 68
Tyagi, A., Agarwal, C., & Agarwal, R. (2002) · PubMed · Cited by 66
Sharma, Y., Agarwal, C., Singh, A. K., & Agarwal, R. (2001) · Molecular Carcinogenesis · doi:10.1002/mc.1032 · Cited by 65
Détaille, D., Sànchez‐Martìn, C., Sanz, N., López-Novoa, J. M., Leverve, X. M., & El‐Mir, M. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.03.007 · Cited by 65
Pferschy‐Wenzig, E., Atanasov, A. G., Malainer, C., Noha, S. M., Kunert, O., Schuster, D., Heiß, E. H., Oberlies, N. H., Wagner, H., Bauer, R., et al. (2014) · Journal of Natural Products · doi:10.1021/np400943b · Cited by 60
Mitochondrial dysfunction in cholestatic liver diseases
Sastre, J. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e539 · Cited by 57
Mitochondrial dysfunction in cholestatic liver diseases
Arduini, A., Serviddio, G., Tormos, A. M., Monsalve, M., & Sastre, J. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/539 · Cited by 56
Oxidative stress modulation in hepatitis C virus infected cells
Lozano-Sepúlveda, S. A., Bryan-Marrugo, O. L., Cordova-Fletes, C., Gutierrez-Ruiz, M. C., & Rivas-Estilla, A. M. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i29.2880 · Cited by 56
Yang, Y., Nemoto, E. M., Harvey, S. A. K., Subbotin, V. M., & Gandhi, C. R. (2004) · Gut · doi:10.1136/gut.2003.024893 · Cited by 53
Involvement of NF-κB and caspases in silibinin-induced apoptosis of endothelial cells
Yoo, H. G., Jung, S. Y., Hwang, Y., Park, J. W., Kim, M. K., Jeong, M., Ahn, S. G., Ahn, B. W., Shin, B. A., Park, R., et al. (2004) · International Journal of Molecular Medicine · doi:10.3892/ijmm.13.1.81 · Cited by 52
Protection against post-ischemic mitochondrial injury in rat liver by silymarin or TUDC
Rolo, A. P., Oliveira, P. J., Moreno, A., & Palmeira, C. M. (2003) · Hepatology Research · doi:10.1016/s1386-6346(03)00108-6 · Cited by 48
Grattagliano, I., Diogo, C. V., Mastrodonato, M., de Bari, O., Persichella, M., Wang, D. Q. ‐., Liquori, A., Ferri, D., Carratù, M. R., Oliveira, P. J., et al. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i20.3007 · Cited by 48
Das, S. K., & Mukherjee, S. (2012) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2012.673090 · Cited by 45
Yang, Z., Zhuang, L., Lu, Y., Xu, Q., & Chen, X. (2014) · BioMed Research International · doi:10.1155/2014/941085 · Cited by 44
Valenzuela, A., Guerra, R., & Argelia Garrido, G. (1987) · Planta Medica · doi:10.1055/s-2006-962757 · Cited by 43
Christodoulou, E., Kechagia, I.-A., Tzimas, S., Balafas, E., Kostomitsopoulos, N. G., Archontaki, H. A., Dokoumetzidis, A., & Valsami, G. N. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.07.060 · Cited by 40
Palaniyandi, S., Padmavathi, R., Magesh, V., & Sakthisekaran, D. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00224.x · Cited by 37
Stanca, E., Serviddio, G., Bellanti, F., Vendemiale, G., Siculella, L., & Giudetti, A. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.07.005 · Cited by 36
Mitochondrial proteolysis: Its emerging roles in stress responses
Sekine, S., & Ichijo, H. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.10.012 · Cited by 35
Ramakrishnan, G., Sundaram, J., Kamaraj, S., Anandakumar, P., & Devaki, T. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1582-1 · Cited by 34
Dunnick, J. K., Singh, B., Nyska, A., Peckham, J., Kissling, G. E., & Sanders, J. M. (2011) · Toxicologic Pathology · doi:10.1177/0192623310394211 · Cited by 32
Milk Thistle (Silybum marianum L. Gaert.) Seeds in Health
Bhattacharya, S. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-375688-6.10090-8 · Cited by 30
Meta-analysis: silymarin and its combination therapy for the treatment of chronic hepatitis B
Wei, F., Liu, S.-K., Liu, X.-Y., Li, Z.-J., Li, B., Zhou, Y., Zhang, H.-Y., & Li, Y.-W. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1789-1 · Cited by 29
Karantonis, H. C., Gribilas, G., Stamoulis, I., Giaginis, C., Spiliopoulou, C., Kouraklis, G. P., Demopoulos, C. A., & Theocharis, S. E. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0745-0 · Cited by 28
New silibinin glyco-conjugates: Synthesis and evaluation of antioxidant properties
Zarrelli, A., Romanucci, V., Tuccillo, C., Federico, A., Loguercio, C., Gravante, R., & Fabio, G. D. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.10.023 · Cited by 28
Self-citationMiele, L., Forgione, A., Hernandez, A. P., Gabrieli, M. L., Vero, V., Rocco, P. D., Greco, A. V., Gasbarrini, G., Gasbarrini, A., & Grieco, A. (2005) · PubMed · Cited by 25
Trappoliere, M., Tuccillo, C., Federico, A., Di Leva, A., Niosi, M., D’Alessio, C., Capasso, R., Coppola, F., D’Auria, M. V., & Loguercio, C. (2005) · PubMed · Cited by 25
Self-citationWood, N. J. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.95 · Cited by 23
Platelet-activating factor in liver injury: A relational scope
Karidis, N. P. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i23.3695 · Cited by 17
Abdel‐Salam, O. M. E., Sleem, A. A., & Shafee, N. (2010) · Inflammopharmacology · doi:10.1007/s10787-009-0027-7 · Cited by 17
Cited by
Bijak, M. (2017) · Molecules · doi:10.3390/molecules22111942 · Cited by 414
Lee, M.-K. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030264 · Cited by 335
Abenavoli, L., Greco, M., Milic, N., Accattato, F., Foti, D., Gulletta, E., & Luzza, F. (2017) · Nutrients · doi:10.3390/nu9080870 · Cited by 144
Metadata
- Authors
- Federico, A., Dallio, M., & Loguercio, C.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2017-01-24
- Volume
- 22
- Issue
- 2
- Pages
- 191
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2580291574
- Cited by
- 492
- References
- 122
- FWCI
- 31.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.